Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023

Glutamate neurotoxicity and diseases of the nervous system

Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188

Biological insights from 108 schizophrenia-associated genetic loci

Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577

From inflammation to sickness and depression: when the immune system subjugates the brain

Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433

Immunobiology: the immune system in health and disease

(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,111

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848

Doxycycline Use in Adolescent Psychiatric Patients and Risk of Schizophrenia: An Emulated Target Trial

Lång, U., Metsälä, J., Ramsay, H., Boland, F., Heikkilä, K., Pulakka, A., Lawlor, A., O’Connor, K., Veijola, J. M., Kajantie, E., et al. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240958 · Cited by 14

Anorexia nervosa and gut microbiome: implications for weight change and novel treatments

Wei, Y., Peng, S., Lian, C., Kang, Q., & Chen, J. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2056017 · Cited by 16

Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort

Foiselle, M., Barbosa, S., Godin, O., Wu, C., Boukouaci, W., André, M., Aouizerate, B., Berna, F. S., Barau, C., Capdevielle, D., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100436 · Cited by 14

Childhood trauma, IL-6 and weaker suppression of the default mode network (DMN) during theory of mind (ToM) performance in schizophrenia

King, S., Mothersill, D., Holleran, L., Patlola, S. R., McManus, R., Kenyon, M., McDonald, C., Hallahan, B. P., Corvin, A. P., Morris, D. W., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100540 · Cited by 14

Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia

Cao, Y., Xu, Y., Xia, Q., Shan, F., & Liang, J. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s420475 · Cited by 15

The causal relationship between immune cell traits and schizophrenia: a Mendelian randomization analysis

Du, J., Baranova, A. V., Zhang, G., & Zhang, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1452214 · Cited by 14

The effect of clozapine on immune-related biomarkers in schizophrenia patients

Shao, L., Yu, L., Yuan, Z., Guo, X., Zeng, G., & Liu, J. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111104 · Cited by 13

Association of the IFN-γ (+874A/T) Genetic Polymorphism with Paranoid Schizophrenia in Tunisian Population

Jemli, A., Esshili, A., Trifa, F., Mechri, A., Zaâfrane, F., Gaha, L., Juckel, G., & Jrad, B. B. H. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1237523 · Cited by 14

Tumor necrosis factor-alpha expression in peripheral blood mononuclear cells correlates with early childhood social interaction in autism spectrum disorder

Makinodan, M., Iwata, K., Ikawa, D., Yamashita, Y., Yamamuro, K., Toritsuka, M., Kimoto, S., Okumura, K., Yamauchi, T., Yoshino, H., et al. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.12.005 · Cited by 14

Proteomic and transcriptional changes associated with MeCP2 dysfunction reveal nodes for therapeutic intervention in Rett syndrome

Marballi, K. K., & MacDonald, J. L. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105076 · Cited by 15

An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birth

Joe, P., Clemente, J. C., Piras, E., Wallach, D. S., Robinson‐Papp, J., Boka, E., Remsen, B., Bonner, M., Kimhy, D., Goetz, D. M., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.09.019 · Cited by 14

Connecting Neurobiological Features with Interregional Dysconnectivity in Social-Cognitive Impairments of Schizophrenia

Adraoui, F. W., Douw, L., Martens, G. J. M., & Maas, D. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097680 · Cited by 14

What’s Hot in Schizophrenia Research?

Weickert, C. S., & Weickert, T. W. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.01.011 · Cited by 14

Clinically Relevant Anti-Neuronal Cell Surface Antibodies in Schizophrenia Spectrum Disorders

Colijn, M. A., & Ismail, Z. (2019) · Neuropsychobiology · doi:10.1159/000499714 · Cited by 14

Detection of autoantibodies against GABAARα1 in patients with schizophrenia

Shiwaku, H., Nakano, Y., Kato, M., & Takahashi, H. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.10.007 · Cited by 14

Gestational influenza and risk of hypomania in young adulthood: prospective birth cohort study

Anderson, J. J., Hoath, S., Zammit, S., Meyer, T. D., Pell, J. P., Mackay, D., & Smıth, D. J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.048 · Cited by 14

Examining the genetic links between clusters of immune-mediated diseases and psychiatric disorders

Breunig, S., Lee, Y. H., Karlson, E. W., Krishnan, A., Lawrence, J. M., Schaffer, L. S., & Grotzinger, A. D. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03470-9 · Cited by 13

Blood‑brain barrier dysfunction in schizophrenia: Mechanisms and implications (Review)

Lv, S., & Luo, C. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5594 · Cited by 18

Rapid and simple analysis of disease-associated biomarkers of Taiwanese patients with schizophrenia using matrix-assisted laser desorption ionization mass spectrometry

Huang, T., Lo, L., Shiea, J., & Su, H. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.08.011 · Cited by 13

Fingertip advanced glycation end products and psychotic symptoms among adolescents

Miyashita, M., Yamasaki, S., Ando, S., Suzuki, K., Toriumi, K., Horiuchi, Y., Yoshikawa, A., Imai, A., Nagase, Y., Miyano, Y., et al. (2021) · Schizophrenia · doi:10.1038/s41537-021-00167-y · Cited by 13

Exploration of the relationship between hippocampus and immune system in schizophrenia based on immune infiltration analysis

Du, Y., Gao, Y., Wu, G., Li, Z., Du, X., Li, J., Li, X., Liu, Z., Xu, Y., & Liu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878997 · Cited by 14

Genetic effects of sequence-conserved enhancer-like elements on human complex traits

Zhu, X., Ma, S., & Wong, W. H. (2024) · Genome biology · doi:10.1186/s13059-023-03142-1 · Cited by 15

System biology approaches to identify hub genes linked with ECM organization and inflammatory signaling pathways in schizophrenia pathogenesis

Bhuiyan, P., Sun, Z., Khan, M. A., Hossain, M. A., Rahman, M. H., & Qian, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25191 · Cited by 14

Schizophrenia, Bipolar Disorder, and Alzheimer’s Disease are not Causal Factors of Bone Mineral Density: A Mendelian Randomization Analysis

Cui, Z., Meng, X., Zhuang, S., Liu, Z., Zhou, F., & Tian, Y. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00625-x · Cited by 13

Reduced levels of circulating adhesion molecules in adolescents with early-onset psychosis

Wedervang‐Resell, K., Ueland, T., Aukrust, P., Friis, S., Holven, K. B., Johannessen, C. H., Lekva, T., Lonning, V., Smelror, R. E., Szabó, A., et al. (2020) · Schizophrenia · doi:10.1038/s41537-020-00112-5 · Cited by 12

Omega-3 and Omega-6 fatty acids and risk of psychotic outcomes in the ALSPAC birth cohort

Thompson, A. D., Jones, H. J., Heron, J., Hibbeln, J. R., Sullivan, S. A., & Zammit, S. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.018 · Cited by 15

Genetic trade‐offs between complex diseases and longevity

Hu, D., Li, Y., Zhang, D., Ding, J., Song, Z., Min, J., Zeng, Y., & Nie, C. (2022) · Aging Cell · doi:10.1111/acel.13654 · Cited by 13

Effect of quetiapine on inflammation and immunity: a systematic review

Ferrari, M., Godio, M., Martini, S., Callegari, C., Cosentino, M., & Marino, F. (2022) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2022.2101928 · Cited by 15

Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures

Lee, J., Xue, X., Au, E., McIntyre, W. B., Asgariroozbehani, R., Panganiban, K. J., Tseng, G. C., Papoulias, M., Smith, E., Monteiro, J., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-023-02716-8 · Cited by 13

Comorbidity between schizophrenia and keratoconus

Schürhoff, F., Leboyer, M., & Szöke, A. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.11.045 · Cited by 13

MRI investigation of immune dysregulation in schizophrenia

Gangadin, S. S., Nasib, L. G., Sommer, I. E., & Mandl, R. C. W. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000498 · Cited by 13

Potential application of helminth therapy for resolution of neuroinflammation in neuropsychiatric disorders

Abdoli, A., & Ardakani, H. M. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00466-5 · Cited by 13

Distinct Inflammation Biomarkers in Healthy Individuals and Patients with Schizophrenia: A Reliability Testing of Multiplex Cytokine Immunoassay by Bland-Altman Analysis

Yeh, T., Chu, H., Tsai, C., Chang, H., Yang, F., Huang, S., & Liang, C. (2019) · Psychiatry Investigation · doi:10.30773/pi.2019.04.14 · Cited by 13

Treatment with the antipsychotic risperidone is associated with increased M1-like JAK-STAT1 signature gene expression in PBMCs from participants with psychosis and THP-1 monocytes and macrophages

Melbourne, J. K., Pang, Y., Park, M. R., Sudhalkar, N., Rosen, C., & Sharma, R. P. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106093 · Cited by 13

Network modules linking expression and methylation in prefrontal cortex of schizophrenia

Lin, D., Chen, J., Duan, K., Perrone‐Bizzozero, N. I., Jing Sui （Beijing Normal University）， my correct affiliation is beijing normal university, N. Q. U. O. S. A. T., Calhoun, V. D., & Liu, J. (2020) · Epigenetics · doi:10.1080/15592294.2020.1827718 · Cited by 13

Zinc as a Neuroprotective Nutrient for COVID-19–Related Neuropsychiatric Manifestations: A Literature Review

Cereda, G., Ciappolino, V., Boscutti, A., Cantù, F., Enrico, P., Oldani, L., Delvecchio, G., & Brambilla, P. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab110 · Cited by 14

Abnormal RasGRP1 Expression in the Post-Mortem Brain and Blood Serum of Schizophrenia Patients

Rosa, A. D., Maio, A. D., Torretta, S., Garofalo, M., Giorgelli, V., Masellis, R., Nuzzo, T., Errico, F., Bertolino, A., Subramaniam, S., et al. (2022) · Biomolecules · doi:10.3390/biom12020328 · Cited by 13

Commentary: Anatomical constitution of sense organs as a marker of mental disorders

Schwitzer, T., Schwan, R., Bernardin, F., Jeantet, C., Angioï-Duprez, K., & Laprévote, V. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00056 · Cited by 13

Commentary: Causal associations between inflammation, cardiometabolic markers and schizophrenia: the known unknowns

Khandaker, G. M. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz201 · Cited by 13

Beyond Latency: Chronic Toxoplasma Infection and Its Unveiled Behavioral and Clinical Manifestations—A 30-Year Research Perspective

Latifi, A., & Jaroslav Flegr, A. (2025) · Biomedicines · doi:10.3390/biomedicines13071731 · Cited by 15

Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence

Bortoletto, R., Piscitelli, F., Candolo, A., Bhattacharyya, S., Balestrieri, M., & Colizzi, M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1231710 · Cited by 12

Identification of Immune-Linked Hub Genes and Diagnostic Model Construction in Schizophrenia

Lian, K., Shen, Z., Yang, R., Ye, J., Shang, B., Dong, L., Li, H., Wu, J., Cheng, Y., & Xu, X. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02138-7 · Cited by 12

Altered levels of cytokine, T- and B-lymphocytes, and PD-1 expression rates in drug-naïve schizophrenia patients with acute phase

Zheng, Y., Zhang, Q., Zhou, X., Yao, L., Zhu, Q., & Fu, Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-49206-x · Cited by 12

The role of immune inflammation in electroconvulsive therapy for schizophrenia: Treatment mechanism, and relationship with clinical efficacy

Wang, Y., & Zhang, X. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115708 · Cited by 12

CLEAR – clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings

Casetta, C., Santosh, P., Bayley, R., Bisson, J. I., Byford, S., Dixon, C., Drake, R., Elvins, R., Emsley, R., Fung, N., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-023-05397-1 · Cited by 13

Rapid detection of alteration of serum IgG in patients with schizophrenia after risperidone treatment by matrix‐assisted laser desorption ionization/time‐of‐flight mass spectrometry

Lo, L., Shiea, J., & Huang, T. (2016) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7753 · Cited by 12

Philosophy of Immunology

Pradeu, T. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108616706 · Cited by 91

AUTOIMMUNE CONCEPT OF SCHIZOPHRENIA: HISTORICAL ROOTS AND CURRENT FACETS

Mayorova, M. A., Георгиевич, Б. Б., Churilov, L. P., Gilburd, B., Petrova, N. N., & Shoenfeld, Y. (2021) · Psychiatria Danubina · doi:10.24869/psyd.2021.3 · Cited by 12

Examining the Association between Inflammation and Motivational Anhedonia in Neuropsychiatric Disorders: A Systematic Review

Nogo, D., Wilkialis, L., Lui, L. M. W., Nasri, F., Rosenblat, J. D., & McIntyre, R. S. (2021) · Annals of Clinical Psychiatry · doi:10.12788/acp.0034 · Cited by 12

Relationship Between Curative Effect and Serum Inflammatory Factors Level in Male Patients With First-Episode Schizophrenia Treated With Olanzapine

Ma, J., Zhang, Y., Huang, Z., Liu, X., Lv, L., & Li, Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.782289 · Cited by 12

Peripheral Blood Levels of Brain-Derived Neurotrophic Factor in Patients with First Episode Psychosis: A Systematic Review and Meta-Analysis

Singh, S., Roy, D., Marzouk, T., & Zhang, J. (2022) · Brain Sciences · doi:10.3390/brainsci12040414 · Cited by 13

Disturbed sensitive equilibrium led by stress‐induced inflammation in psychiatric illness

Zhao, H., Jin, R., & Hu, J. (2022) · General Psychiatry · doi:10.1136/gpsych-2022-100910 · Cited by 12

Clinical and biological correlates of optical coherence tomography findings in schizophrenia

Kurtulmuş, A., Şahbaz, Ç., Elbay, A., Güler, E. M., Avaroglu, G. S., Koçyiğit, A., Ozdemir, M. H., & Kırpınar, İ. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01587-w · Cited by 12

Altered neutrophil-to-lymphocyte ratio in patients with non-affective first episode psychosis and its relationship with symptom severity and cognitive impairment

Leung, K. K., Wong, Y. C., Shea, K. S. C., Chan, S. C., Chang, W. C., Mo, Y. M. F., & Chan, S. S. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-37846-y · Cited by 16

Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study

Ye, J., Wei, Y., Zeng, J., Gao, Y., Tang, X., Xu, L., Hu, Y., Liu, X., Liu, H., Chen, T., et al. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s418381 · Cited by 12

Schizophrenia in the genetic era: a review from development history, clinical features and genomic research approaches to insights of susceptibility genes

Lv, Y., Wen, L., Hu, W.-J., Deng, C., Ren, H., Bao, Y.-N., Su, B.-W., Gao, P., Man, Z., Luo, Y.-Y., et al. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01271-x · Cited by 13

The relationship between inflammatory markers, clinical characteristics, and cognitive performance in drug-naïve patients with schizophrenia

Sun, X., Luo, G., Li, X., Wang, J., Qiu, Y., Li, M., & Li, J. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01677-9 · Cited by 12

Long-Term Fluoxetine Administration Causes Substantial Lipidome Alteration of the Juvenile Macaque Brain

Tkachev, A., Stekolshchikova, E., Bobrovskiy, D. M., Anikanov, N. A., Ogurtsova, P., Park, D. I., Horn, A. K. E., Petrova, D., Khrameeva, E. E., Golub, M. S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158089 · Cited by 12

Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia

Fu, Y. Y., Zhang, T., Xiu, M. H., Tang, W., Han, M., Yun, L., Chen, D. C., Chen, S., Tan, S., Soares, J. C., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.05.010 · Cited by 12

Transcranial sonography in psychiatry as a potential tool in diagnosis and research

Drepper, C., Geissler, J. M., Pastura, G. M. C., Yılmaz, R., Berg, D., Romanos, M., & Gerlach, M. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1386325 · Cited by 12

Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA Working Groups on CNVsPreprint

Sønderby, I. E., Ching, C. R. K., Thomopoulos, S. I., van der Meer, D., Villalón‐Reina, J. E., Agartz, I., Amunts, K., Arango, C., Armstrong, N. J., Ayesa‐Arriola, R., et al. (2021) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/57erc · Cited by 11

Effects of Current Psychotropic Drugs on Inflammation and Immune System

Bhatt, S., Dhar, A. K., Samanta, M. K., & Suttee, A. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_18 · Cited by 12

Peering into the mind: unraveling schizophrenia’s secrets using models

Nani, J. V. S., Muotri, A. R., & Hayashi, M. A. F. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02728-w · Cited by 11

Mitochondrial Dysfunction and Cognitive Impairment in Schizophrenia: The Role of Inflammation

Wang, G., Liu, S., Fan, X., Li, J., Xue, Q., Liu, K., Li, X., Yang, Y., Wang, X., Song, M., et al. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae196 · Cited by 14

The complex association between the antioxidant defense system and clinical status in early psychosis

García, S., Alberich, S., Martínez‐Cengotitabengoa, M., Arango, C., Castro‐Fornieles, J., Parellada, M., Baeza, I., Moreno, C., Micó, J. A., Berrocoso, E., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194685 · Cited by 11

Comparison of thin-strut cobalt-chromium stents and stainless steel stents in a porcine model of neointimal hyperplasia.

Milewski, K. P., Żurakowski, A., Pająk, J., Pajak-Zielinska, E., Liszka, Ł., Buszman, P. P., Bis, J., Dębiński, M., & Buszman, P. E. (2010) · PubMed · Cited by 11

Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences

Santo, F. D., González-Blanco, L., García-Álvarez, L., de la Fuente-Tomás, L., Velasco, Á., Alvarez-Vázquez, C., Martínez-Cao, C., Sáiz, P. A., García‐Portilla, M. P., & Bobes, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-73043-x · Cited by 12

Cannabis Cessation, Inflammatory Markers and Schizophrenia

Roméo, B., Lestra, V., Martelli, C., Benyamina, A., & Hamdani, N. (2022) · Journal of Dual Diagnosis · doi:10.1080/15504263.2021.2013697 · Cited by 11

Gender-associated role in patients with schizophrenia. Is there a connection with the resistance?

Panov, G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.995455 · Cited by 11

From gut to brain: A network model of intestinal permeability, inflammation, and psychotic symptoms in schizophrenia.

Santo, F. D., González-Blanco, L., García‐Portilla, M. P., Alfonso, M., Hernández, C., Sánchez-Autet, M., Bernardo, M., Anmella, G., Amoretti, S., Safont, G., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.10.004 · Cited by 11

Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naïve patients with treatment-resistant schizophrenia

He, J., Li, J., Wei, Y., He, Z., Liu, J., Yuan, N., Zhou, R., He, X., Ren, H., Gu, L., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05689-0 · Cited by 11

L’activité physique chez les patients atteints de schizophrénie : de la neurobiologie aux bénéfices cliniques

Tréhout, M., & Dollfus, S. (2018) · L Encéphale · doi:10.1016/j.encep.2018.05.005 · Cited by 17

Associations of neural processing of reward with posttraumatic stress disorder and secondary psychotic symptoms in trauma-affected refugees

Uldall, S. W., Nielsen, M. Ø., Carlsson, J. M., Glenthoj, B. Y., Siebner, H. R., Madsen, K. H., Madsen, C. G., Leffers, A.-M., Nejad, A. B., & Rostrup, E. (2020) · European Journal of Psychotraumatology · doi:10.1080/20008198.2020.1730091 · Cited by 11

Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder

Szabó, A., Akkouh, I. A., Ueland, T., Lagerberg, T. V., Dieset, I., Bjella, T. D., Aukrust, P., Hellard, S. L., Stavrum, A.-K., Melle, I. S., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00642 · Cited by 9

Antibodies Against the NH2-Terminus of the GluA Subunits Affect the AMPA-Evoked Releasing Activity: The Role of Complement

Cisani, F., Olivero, G., Usai, C., Camp, G. V., Maccari, S., Morley‐Fletcher, S., & Pittaluga, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.586521 · Cited by 11

Plasma Soluble P-selectin, Interleukin-6 and S100B Protein in Patients with Schizophrenia: a Pilot Study

Pinjari, O. F., Dasgupta, S. K., & Okusaga, O. O. (2021) · Psychiatric Quarterly · doi:10.1007/s11126-021-09954-3 · Cited by 11

A pilot case-control study on the association between N-acetyl derivatives in serum and first-episode schizophrenia

Huang, N., Cao, B., Brietzke, E. M., Park, C., Cha, D. S., Pan, Z., Zhu, J., Liu, Y., Xie, Q., Zeng, J., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.11.064 · Cited by 11

Maximising the potential of neuroimmunology

Caldwell, L. J., Subramaniam, S., MacKenzie, G., & Shah, D. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.010 · Cited by 11

Elevated plasma matrix metalloproteinase 9 in schizophrenia patients associated with poor antipsychotic treatment response and white matter density deficits

Li, X., Wang, X., Yang, Y., Zhou, J., Wu, X., Zhao, J., Zhang, J., Guo, X., Shao, M., Song, M., et al. (2024) · Schizophrenia · doi:10.1038/s41537-024-00494-w · Cited by 10

The association between hematological markers of inflammation and chronic cannabis use: a systematic review and meta-analysis of observational studies

Moshfeghinia, R., Najibi, A., Moradi, M., Assadian, K., & Ahmadi, J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1438002 · Cited by 13

Maternal immune activation followed by peripubertal stress combinedly produce reactive microglia and confine cerebellar cognition

Hikosaka, M., Parvez, M. S. A., Yamawaki, Y., Oe, S., Yuan, L., Wada, Y., Hirahara, Y., Koike, T., Imai, H., Oishi, N., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-07566-2 · Cited by 13

The anti-inflammation pharmacodynamics of lithium: Therapy of bipolar disorder

Zhou, Y., Zheng, W., Guo, F., Wu, S., & Zhong, C. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251326942 · Cited by 11

A study on the association of genes for pro-inflammatory cytokines and depression

Лежейко, Т. В., Andryushchenko, A. V., Коровайцева, Г. И., Kondratyev, N. V., Gabaeva, M. V., Крикова, Е. В., & Голимбет, В. Е. (2018) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20181183189-93 · Cited by 10

¿Pueden ser la interleucina-2 y la interleucina-1β biomarcadores específicos de la sintomatología negativa en la esquizofrenia?

González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., Rodríguez‐González, S., Coto‐Montes, A. M., & Bobes, J. (2018) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2018.03.004 · Cited by 10

Progress in mechanistically novel treatments for schizophrenia

Neef, J., & Palacios, D. S. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00096a · Cited by 10

Can the current schizophrenia construct endure?

Kelly, D. L., & Buchanan, R. W. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2021.12.028 · Cited by 10

To Boldly Go Where One Has Gone Before.

Kelley, K. (2017) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2017.08.013 · Cited by 8

A Destruction Model of the Vascular and Lymphatic Systems in the Emergence of Psychiatric Symptoms

Segawa, K., Blumenthal, Y., Yamawaki, Y., & Ohtsuki, G. (2021) · Biology · doi:10.3390/biology10010034 · Cited by 11

TLR7 and IL-6 differentially regulate the effects of rotarod exercise on the transcriptomic profile and neurogenesis to influence anxiety and memory

Hung, Y.-F., & Hsueh, Y. (2021) · iScience · doi:10.1016/j.isci.2021.102384 · Cited by 10

White matter microstructural associates of apathy-avolition in schizophrenia

Abdolalizadeh, A., Ostadrahimi, H., Ohadi, M. A. D., Saneei, S. A., & Ershadi, A. S. B. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.07.042 · Cited by 10

Systematic Review and Meta-Analysis of Damage Associated Molecular Patterns HMGB1 and S100B in Schizophrenia

Mackey, M., Holleran, L., Donohoe, G. J., & McKernan, D. P. (2022) · Psychiatry Investigation · doi:10.30773/pi.2022.0173 · Cited by 10

Toll-Like Receptor (TLR) 1, 2, and 6 Gene Polymorphisms Support Evidence of Innate Immune Factors in Schizophrenia

Sotelo-Ramírez, C. E., Camarena, B., Sanabrais‐Jiménez, M. A., Zaragoza-Hoyos, J. U., Ordoñez-Martínez, B., Escamilla-Orozco, R. I., & Gómez‐González, B. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s420952 · Cited by 9

Molecular mapping of a core transcriptional signature of microglia-specific genes in schizophrenia

Fiorito, A. M., Fakra, É., Sescousse, G., Ibrahim, E. C., & Rey, R. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02677-y · Cited by 9

Immunoinflammatory features and cognitive function in treatment-resistant schizophrenia: unraveling distinct patterns in clozapine-resistant patients

Li, Y., Zhu, M., Dong, Y., Liu, N., Wang, X., Yang, B., Li, Z., & Li, S. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01885-x · Cited by 9

A Multi-Omics Integration Framework with Automated Machine Learning Identifies Peripheral Immune-Coagulation Biomarkers for Schizophrenia Risk Stratification

Hong, F., Chen, Q., Luo, X., Xie, S., Wei, Y., Li, X., Li, K., Lebeau, B., Ling, C. C. Y., Dao, F., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157640 · Cited by 9

Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome

Zafarullah, M., Angkustsiri, K., Quach, A., Yeo, S., Durbin-Johnson, B. P., Bowling, H. L., & Tassone, F. (2024) · Metabolomics · doi:10.1007/s11306-024-02088-0 · Cited by 9

B Cell-activating factor (BAFF): A promising trans-nosographic biomarker of inflammation and autoimmunity in bipolar disorder and schizophrenia

Boukouaci, W., Lajnef, M., Wu, C., Bouassida, J., Saitoh, K., Sugunasabesan, S., Richard, J., Apavou, M., Lamy, A., Henensal, A., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.025 · Cited by 9

Inflammation proteomic profiling of psychosis in young adults: Findings from the ALSPAC birth cohort

Tsang, R. S. M., Timpson, N. J., & Khandaker, G. M. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107188 · Cited by 10

Experimental drugs for bipolar psychosis

Fornaro, M., Nardi, A. E., Berardis, D. D., & Carta, M. G. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1256390 · Cited by 9

Analysis of plasma autoantibodies for inflammatory cytokines in patients with first-episode schizophrenia among a Chinese population

Liu, S., Zhang, X., Wang, J., Yang, H., Jiang, Y., Qiu, C., & Meng, Q. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577165 · Cited by 9

Implications of immunity and inflammation in schizophrenia and related psychotic disorders

Perestrelo, J., Mota, D. C. M., Coutinho, A., Santos, M. A. B. D., & Lapa, G. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2016.01.2163

Imunne system and schyzophrenia

Almeida, A., Teixeira, T. M., & Quarenta, J. (2022) · European Psychiatry · doi:10.1192/j.eurpsy.2022.1806

Imunologia da esquizofrenia: evidências, perspectivas e desafios

de Campos-Carli, S. M., Salgado, J. V., & Teixeira, A. L. (2016) · Debates em Psiquiatria · doi:10.25118/2763-9037.2016.v6.136

Is there a role for immune-to-brain communication in schizophrenia?

Khandaker, G. M., & Dantzer, R. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3975-1 · Cited by 170

The Role of Inflammation in the Etiology and Treatment of Schizophrenia

Köhler-Forsberg, O., & Lennox, B. (2020) · Frontiers research topics · doi:10.3389/978-2-88966-269-2 · Cited by 2